Mountain Scholar

Total Page:16

File Type:pdf, Size:1020Kb

Mountain Scholar According To Industry Official Federal Grand Jury Indicts Four Refiners New Versions of HFGS Will Lead A federal grand jury in Brooklyn indicted four Northeastern companies on charges they conspired to fix the To Growth As Sugar Replacement prices of cane sugar sold for indu.strial pl'rposes. Donald E. Nordlund, chairman of that new versions of HFCS will lead Kamed as defendants are SuCrest A. E. Staley Manufacturing Co. of De­ to its further growth as a sugar re­ Corp., New York, PepsiCo Inc., Pur­ catur, Ill., a major producer of high placement and cited a 90 per cent ch,i.se, N.Y.; RSN Projects Inc., New fructose corn syrup (HFCS) said in a fructose product with potential in low York, and CPC International Inc., talk to The New York Sugar Club calorie foods and beverages, a 55 per Englewood Cliffs, N.J. cent product for use in soft drinks, According to the indictment. the and in the longer term, a crystalline price-fixing l::egan in August, 1972, ::,-:r;?ame Awaits fru~tose for "the consumer's sugar soon after Amstar Corp. the nation's bowl." largest sugar refiner, announced a new Approval Nordlund, however, tempered his pricing policy that eliminated dis­ predictions on HFCS's significant in­ counts and provided for the sc:le of Aspartame, a non-sugar sweetener, roads with a remark that sugar will refined industrial sugar at list prices. is awaiting FDA approval and may remain the standard of the sweetener The indictment alleges that the provide America's 10 million diabetics industry for years to come. four defendants discussed Am3tar's and 150 million diet conscious people But, "we can expect the sweetener policy with each other and agreed to with a low-calorie substitute for sac­ industry to be in a state of transition start similar policies. charin if the proposed ban on sac­ as the result of technical developments "The prices of refined indi.:strial charin is carried out. The product is not just from corn wet millers, but cane sugar were raised, fixed. and intended for use in soft drinks, cereals, from sugar refiners as well," he noted. stabilized at noncompetitive levels," confections, desserts, chewing gum and Coming back to HFCS production, the indictment says. "Purchasers of granulated sweeteners. the Staley chief executive told the refined industrial cane sugar were de­ "Aspartame is a totally new kind of sugar industry officials that interest prived of free and open competition in sweetener made from two amino acids in the 90 per cent fructose product. the purchase of sugar," it adds. which are already consumed in more which is about one-and-one-half times Refined industrial sugar is sold to than half the foods we eat everyday," sweeter than sugar, has increased manufacturers for use . in food and explains Dr. John H. Rust, professor · sharply since the recent proposed ban beverages. From August, 1972, to Sep­ emeritus at the University of Chicago's on saccharin. He said the ability to tember, 1973, the period covered by Pritzker School of Medicine. "Amino produce such a product is limited but the indictment, the four companies acids are commonly found in meat, could be increased if the ban becomes sold about $257 million of industrial milk and vegetables. Aspartame is effective. sugar, the indictment says. metabolized in the body in the same In addition, a new 55 per cent fruc­ If convicted, the companies face way as the amino acids in these foods." tose product is now being aimed at maximum fines of $50,000 each. 180 times sweeter than sugar, only the soft drink industry, Nordlund said. a small amount of aspartame is needed "The crystalline high fructose pro­ The New York grand jury was con­ to sweeten foods, resulting in a signifi­ duct," Nordlund said, "is in the labor­ vened in October, 1974. In January, cant calorie reduction. atory states but could become com­ 1975, Amstar, CPC International Su­ The sweet property of aspartame mercially available in the early 1980s.'' Crest and Savannah Foods & Indus­ was discovered by chemists at the G. The Staley chairman emphasized tries Inc. said they had been served S. Searle Co., Skokie, Ill., 12 years ago. that markets for HFCS will develop to with subpoenas to produce informa­ In 1974 the FDA approved its sale as consume the increased output, but not tion for a grand jury investigation of a non-sugar sweetener in the U.S., but as fast as the new capacity comes on­ price-fixing by refiners in 1973 and because certain scientific questions stream. He said that additional new 1974. were raised regarding its metabolism high fructose entries are unlikely for It was believed at the time that the by the body, the company voluntarily the next few years but predicted fruc­ grand jury would be investigating withheld aspartame from the market. tose supply-demand would begin to whether the sugar refiners conspired Searle has conducted further studies reach equilibrium in the next year or to keep rawsugar prices artificially and this new data has recently been so. high during a period of sharp price presented to the FDA. Nordlund credited the growth in increases in 1973 and 1974. During high fructose even at lower sugar 1974, the wholesale price for a po_und prices to two sources: customers who of sugar surged to a record 74.8 cents Taiwan Crop Up are increasing their use as they gain a pound in November from 17.2 cents Taiwan is expected to turn out confidence in the product, and first­ a pound in January. 900,000 tons of sugar this year with time users who waited to see if its That investigation is completed and two-thirds planned for export, the Tai­ economic advantage would be main­ there apparently won't be any further wan Sugar Corp. reported. tained against low sugar prices. indictments, a spokesman for the Jus­ The export value is set at $150 mil­ High fructose corn syrup would tice Department said in Washington. lion. Last year Taiwan produced 780,- continue to progress regardless of U.S. "This will probably be the only 0CO tons of sugar and exported 500,000 sugar policy changes, short of corn indictment to come from that grand to:is valued at $147 million. sweetener legislation, Nordlund added. jury," the spokesman added. Page 12 SUGARBEET GROWER/April 1977 danger of any kind has emerged, says Grapefruit Peel Dr. Arthur Morgan, director of the L11karis To Head USDA research laboratory in Albany. ~ May Provide Su ar Calif. I Gourmet Foods FDA officials point out, however, Substitute Sour~~ that the grapefruit-peel sweetener has Gourmet Food Products, Inc. has some drawbacks. announced the appointment of Robert America may well get its next sug­ The substance sometimes leaves a D. Lukaris as Executive Vice Presi­ ar substitute from the lowly grapefruit bitter aftertaste - as did saccharin - dent and General Manager. peel. and it may not stay sweet for long Government scientists are n ow periods in diet drinks. Federal re­ Rowland M. Cannon, chairman of testing a natural sweetener found in searchers now are trying to solve the board of Gourmet. said the ap­ those peels that could turn out to be those problems. pointment w as made at a regular a replacement for saccharin, on which Still, USDA officials say, the peel monthly board meeting at the Bo3rd­ the U. S. Food and Drug Administra­ extract appears to offer the best hope man plant. Lukaris will be responsible tion (FDA) has proposed a ban. for oevrall operational management Without such a substitute, Amer­ for quickly finding an acceptable r e­ placement for saccharin. Several com­ of the processing facilities of Gourmet ica's diabetics and weight watchers, and their support services. who together consume vast quantities panies already have asked the FDA of diet foods and soft drinks contain­ for permission to market the new sug­ ar substitute. Lukaris has been operations man­ ing saccharin, will not have an ap­ ager for Gourmet at its Boardman proved sugarless sweetener when and Testing of this chemical was pro­ plant since it went into production in if the ban takes effect this summer. ceeding with little public attention 1975. This modern plant and an older The chemical now undergoing tests until the FDA proposed banning sac­ one at Metolius produce frozen french is about 3,000 times sweeter than sug­ charin by July because Canadian tests fried and hash brown potato products. ar but, like saccharin, it has no calor­ suggested that it caused bladder can­ ies. It was discovered in 1965 by U. S. cer in rats. A native of San Francisco, he at­ Department of Agriculture (USDA) FDA officials in Washington say tended College of San Mateo. For two researchers in California who were that the natural sweetener, called neo­ years prior to joining Gourmet, he was seeking uses for waste products from h esp er id i n e dehydrochalcone, has operations manager for Pride Pak that region's farms and fruit groves. something of a head start in its Foods at its Richland, Washington, Since the discovery, thousands of lengthy approval procedures because plant, and before that was general laboratory animals have been fed many of the animals tests, beginning manager for a Del Monte Foods pro­ large quantities of the super-sweet in the mid-1960s, were designed in co­ cessing plant in the San Francisco bay chemical. No evidence of toxicity or operation with the FDA. area. ;, l-Pg. 28 The Times-Picayune '1'11ursday, Juue ~:s, h'U . .! . ~·~·¢cJturin(;i\Yj tfl.L a/b~l ;, W~:r..1\jng :, Q·~qk~.qwf ti\i 1 ~ ~: ~y RICBA~D SALTUS · .
Recommended publications
  • Overruling the Food and Drug Administration
    Overruling the Food and Drug Administration: An Analysis of the 2011 Denial of Over-the-Counter Status for Plan B Placed within the Historical Context of Executive Influence on FDA Action The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Alisha Crovetto, Overruling the Food and Drug Administration: An Analysis of the 2011 Denial of Over-the-Counter Status for Plan B Placed within the Historical Context of Executive Influence on FDA Action (May 2012). Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:10985168 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA Overruling the Food and Drug Administration: An Analysis of the 2011 Denial of Over-the-Counter Status for Plan B Placed within the Historical Context of Executive Influence on FDA Action Alisha Crovetto Harvard Law School J.D. Candidate, 2013 May 2012 Food & Drug Law Course Paper Abstract On December 7, 2011, newspaper headlines from coast to coast announced that Plan B One-Step, a form of emergency contraception, would not be made available to females under seventeen without a prescription. The denial of over-the-counter (“OTC”) status, though newsworthy itself, drew particular attention because of the unusual nature of the decision. As the New York Times announced, “[f]or the first time ever, the Health and Human Services secretary publicly overruled the Food and Drug Administration .
    [Show full text]
  • Masakazu Konishi
    Masakazu Konishi BORN: Kyoto, Japan February 17, 1933 EDUCATION: Hokkaido University, Sapporo, Japan, B.S. (1956) Hokkaido University, Sapporo, Japan, M.S. (1958) University of California, Berkeley, Ph.D. (1963) APPOINTMENTS: Postdoctoral Fellow, University of Tübingen, Germany (1963–1964) Postdoctoral Fellow, Division of Experimental Neurophysiology, Max-Planck Institut, Munich, Germany (1964–1965) Assistant Professor of Biology, University of Wisconsin, Madison (1965–1966) Assistant Professor of Biology, Princeton University (1966–1970) Associate Professor of Biology, Princeton University (1970–1975) Professor of Biology, California Institute of Technology (1975– 1980) Bing Professor of Behavioral Biology, California Institute of Technology (1980– ) HONORS AND AWARDS (SELECTED): Member, American Academy of Arts and Sciences (1979) Member, National Academy of Sciences (1985) President, International Society for Neuroethology (1986—1989) F. O. Schmitt Prize (1987) International Prize for Biology (1990) The Lewis S. Rosenstiel Award, Brandeis University (2004) Edward M. Scolnick Prize in Neuroscience, MIT (2004) Gerard Prize, the Society for Neuroscience (2004) Karl Spencer Lashley Award, The American Philosophical Society (2004) The Peter and Patricia Gruber Prize in Neuroscience, The Society for Neuroscience (2005) Masakazu (Mark) Konishi has been one of the leaders in avian neuroethology since the early 1960’s. He is known for his idea that young birds initially remember a tutor song and use the memory as a template to guide the development of their own song. He was the fi rst to show that estrogen prevents programmed cell death in female zebra fi nches. He also pioneered work on the brain mechanisms of sound localization by barn owls. He has trained many students and postdoctoral fellows who became leading neuroethologists.
    [Show full text]
  • The Diet Industry the Diet Industry
    Issue: The Diet Industry The Diet Industry By: Lisa Rabasca Roepe Pub. Date: March 5, 2018 Access Date: September 24, 2021 DOI: 10.1177/237455680408.n1 Source URL: http://businessresearcher.sagepub.com/sbr-1946-105904-2881576/20180305/the-diet-industry ©2021 SAGE Publishing, Inc. All Rights Reserved. ©2021 SAGE Publishing, Inc. All Rights Reserved. Will it adapt to changing attitudes? Executive Summary The $70.3 billion industry for diet products and plans is experiencing a shakeout as consumer perceptions shift. The industry still fills a need, since about 70 percent of U.S. adults are overweight or obese, according to government data. But attitudes about how to control weight are changing, as many dieters bounce from one plan to another without finding satisfaction. Many give up on dieting altogether in favor of a broader approach that emphasizes eating a wider variety of foods, exercising and seeking to sustain a healthy lifestyle. In addition, new competitors are entering the field to challenge the traditional industry leaders, but the established firms are finding ways to survive in the changing climate. Key takeaways include: The year 2017 was a period of recovery for the industry after several down years for major players such as Weight Watchers. One well-established company, Nutrisystem, has been especially successful in adapting to a changing business environment by seeking partnerships with major retailers. Fitness apps and trackers, once seen as a potential industry disrupter, have had a mixed record, in part because owners often stop using them after a few months. Click hear to listen to an interview with author Lisa Rabasca Roepe.
    [Show full text]
  • The Need to Shorten the Prescription Drug Approval Process
    Valparaiso University Law Review Volume 27 Number 1 Fall 1992 pp.95-137 Fall 1992 Getting There First With the Best: The Need to Shorten the Prescription Drug Approval Process Mark A. Kassel Follow this and additional works at: https://scholar.valpo.edu/vulr Part of the Law Commons Recommended Citation Mark A. Kassel, Getting There First With the Best: The Need to Shorten the Prescription Drug Approval Process, 27 Val. U. L. Rev. 95 (1992). Available at: https://scholar.valpo.edu/vulr/vol27/iss1/3 This Notes is brought to you for free and open access by the Valparaiso University Law School at ValpoScholar. It has been accepted for inclusion in Valparaiso University Law Review by an authorized administrator of ValpoScholar. For more information, please contact a ValpoScholar staff member at [email protected]. Kassel: Getting There First With the Best: The Need to Shorten the Presc Notes GETTING THERE FIRST WITH THE BEST: THE NEED TO SHORTEN THE PRESCRIPTION DRUG APPROVAL PROCESS I. INTRODUCTION Due to unnecessary time delays, high costs and safety concerns, drug regulation in the United States is in need of reform.' The United States consistently lags behind the rest of the developed world in the approval of new, innovative, and efficient medications.2 Therefore, the Food and Drug Administration (FDA) needs to implement creative and effective changes in the prescription drug approval process3 in order to protect the health of the American public. Most Americans think that the FDA's stringent process for approving new prescription drugs guarantees that prescription drugs are successfully monitored.4 The American public assumes that safe and innovative drugs are made available to the public as quickly' and cost effectively6 as possible, while unsafe7 products are kept off the market.' However, this confidence placed in the FDA is unwarranted.
    [Show full text]
  • Clear Liquid Diet for Diabetics
    CLEAR LIQUID DIET FOR DIABETICS Important Facts About Diet: 1. The liquid meal plan that is given to you will replace only the calories that you would normall get from the carbohydrates containing foods in your diet (such as breads, starches, cereals, fruits, and vegetables.) For Example: the plan that replaces a 1500 calorie diet will provide approximately 900 calories. If you replaced all the calories in your diet with juices and sweetened beverages, it could cause your blood sugar to be too high. 2. You will reduce your normal dosage of daily insulin to 2/3 normal dosage on each day you are on clear liquids. Do NOT take insulin the morning of your test, however, it is very important that you bring your insulin with you. Basic List of Foods Considered As Clear Liquids: (NO MILK OR MILK PRODUCTS) Soft drinks (regular, not Sugar-Free) Gatorade (NO RED or PURPLE) Fat-Free Broth or Boullion Lemonade (powdered) Jello – Yellow or Green only Popsicles (only clear fruit flavored) Coffee Fruit Juice / Drinks (NO PULP) (NO RED or PURPLE) Tea Kool-Aid (NO RED or GRAPE) DIABETIC CLEAR LIQUID DIET FOOD GROUPS: Group A (each serving contains about 40 calories) Apple Juice 1/3 cup Fruit Juice ½ cup Lemonade ½ cup Sugar 1 Tbsp. Lemon-Lime Soda ½ cup Gingerale ½ cup White Cranberry Juice ¼ cup Sweetened Gelatin ¼ cup Popsicle ½ Twin Bar Fat-Free Broth/Boullion - any amount Group B (each serving contains about 60 calories) Apple Juice 1/3 cup White Cranberry Juice 1/3 cup Lemonade ¾ cup Gingerale ¾ cup Lemon-Lime Soda ¾ cup Fat-Free Broth/Boullion -any
    [Show full text]
  • 1. Exposure Data
    1. EXPOSURE DATA 1.1 Identification of the agents by-products such as blood. It is also important to distinguish between industrial processing The focus of thisMonograph is the consump- and household preparations. As there is a huge tion of red meat and processed meat. These terms variety of processed meat products, it is difficult are defined below. to sort them into categories (Santarelli et al., 2008). However, based on recommendations by 1.1.1 Red meat the Food and Agriculture Organization of the United Nations (FAO) (Heinz & Hautzinger, Red meat refers to fresh unprocessed 2007), different groups of industrial processed mammalian muscle meat (e.g. beef, veal, pork, meats can be proposed. lamb, mutton, horse, or goat meat), which may be minced or frozen, and is usually (a) Cured meat pieces consumed cooked. Examples of cured meat include raw beef, raw 1.1.2 Offal ham, cooked beef, cooked ham, corned beef, and bacon. Mammalian offal refers to the internal Curing is a process by which the meat is organs and entrails of a butchered animal (e.g. treated with a small amount of salt (sodium scrotum, small intestine, heart, brain, kidney, chloride, NaCl, with or without potassium chlo- liver, thymus, pancreas, testicle, tongue, tripe, or ride, KCl), with or without nitrate or nitrite salts. stomach) consumed as such. Mammalian offal Curing enhances shelf-life by preserving and is considered to be a specific food category in preventing the spoilage of meat. Cured meat cuts food consumption surveys (FAO, 2015); however, are made of entire pieces of muscle meat and can mammalian offal is reported together with red be subdivided into two groups: cured raw meats meat in some epidemiological studies.
    [Show full text]
  • Mediterranean Diet Food: Strategies to Preserve a Healthy Tradition
    imental er Fo p o x d E C Journal of Experimental Food f h o e l m a n i Boskou, J Exp Food Chem 2016, 1:1 s r t u r y o J Chemistry DOI: 10.4172/2472-0542.1000104 ISSN: 2472-0542 Review Article open access Mediterranean Diet Food: Strategies to Preserve a Healthy Tradition Dimitrios Boskou* Aristotle University of Thessaloniki, Greece *Corresponding author: Dimitrios Boskou, Aristotle University of Thessaloniki, Greece, Tel: +30 2310997791; E-mail: [email protected] Received date: September 21, 2015; Accepted date: November 28, 2015; Published date: December 7, 2015 Copyright: © 2015 Boskou D. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Abstract The traditional Mediterranean diet refers to a dietary pattern found in olive growing areas of the Mediterranean region. It’s essential characteristic is the consumption of virgin olive oil, vegetables, fresh fruits, grains, pasta, bread, olives, pulses, nuts and seeds. Moderate amounts of fish, poultry, dairy products and eggs are consumed with small amounts of red meat and wine. Over the past few decades there has been a growing interest in the role of the Mediterranean diet in preventing the development of certain diseases, especially cardiovascular disease. Mediterranean food products are now re-evaluated for the beneficial health effects in relation to the presence of bioactive compounds. The body of science unraveling the role of bioactives such as phenolic acids, various polyphenols, flavonoids, lignans, hydroxyl-isochromans, olive oil secoiridoids, triterpene acids and triterpene alcohols, squalene, αlpha-tocopherol and many others is growing rapidly.
    [Show full text]
  • Incorporating Away-From-Home Foods Into a Healthy Eating Plan
    Incorporating Away–From–Home Food into a Healthy Eating Plan Summary Much of this brief is based upon a In our often time-pressed society, convenience is a recently published way of life for many individuals. Foods and meals report: The prepared outside of the home are an increasingly Keystone Forum 1, 2 important part of the American diet. This is a on Away-From- trend that has coincided with a dramatic rise in the Home Foods: prevalence of obesity. While food, wherever prepared, Opportunities for is not the only factor affecting body weight, away- Preventing Weight from-home food should be an important consideration Gain and Obesity.3 for people aiming to maintain or lose weight. A The report resulted growing body of literature indicates that the eating from consensus of away-from-home food can be a factor influencing building workshops energy intake. Informed choices pertaining to away- which included from-home food could help reduce calorie over­ participants from consumption and aid in weight management. the private sector, nongovernmental The objectives of this brief are to: organizations, Summarize environmental and societal changes academia, and government to “identify the state of that may contribute to the increased consumption of the evidence, as well as, important knowledge gaps, away-from-home food. regarding obesity and weight gain prevention and away-from-home foods.” Review the properties of away-from-home-food that may facilitate the over-consumption of energy. In this brief, away-from-home food refers to food Examine studies investigating the relationship of prepared and purchased outside of the home.
    [Show full text]
  • Donald Griffin Was Able to Affect a Major Revolution in What Scien- Tists Do and Think About the Cognition of Nonhuman Ani- Mals
    NATIONAL ACADEMY OF SCIENCES DONALD R. GRIFFIN 1915– 2003 A Biographical Memoir by CHARLES G. GROSS Any opinions expressed in this memoir are those of the author and do not necessarily reflect the views of the National Academy of Sciences. Biographical Memoirs, VOLUME 86 PUBLISHED 2005 BY THE NATIONAL ACADEMIES PRESS WASHINGTON, D.C. DONALD R. GRIFFIN August 3, 1915–November 7, 2003 BY CHARLES G. GROSS OST SCIENTISTS SEEK—but never attain—two goals. The M first is to discover something so new as to have been previously inconceivable. The second is to radically change the way the natural world is viewed. Don Griffin did both. He discovered (with Robert Galambos) a new and unique sensory world, echolocation, in which bats can perceive their surroundings by listening to echoes of ultrasonic sounds that they produce. In addition, he brought the study of animal consciousness back from the limbo of forbidden topics to make it a central subject in the contemporary study of brain and behavior. EARLY YEARS Donald R. (Redfield) Griffin was born in Southampton, New York, but spent his early childhood in an eighteenth- century farmhouse in a rural area near Scarsdale, New York. His father, Henry Farrand Griffin, was a serious amateur historian and novelist, who worked as a reporter and in advertising before retiring early to pursue his literary inter- ests. His mother, Mary Whitney Redfield, read to him so much that his father feared for his ability to learn to read. His favorite books were Ernest Thompson Seton’s animal 3 4 BIOGRAPHICAL MEMOIRS stories and the National Geographic Magazine’s Mammals of North America.
    [Show full text]
  • The National Academies Committee on a New Government-University
    NOTE: This is an unedited verbatim transcript of the Workshop on a New Government-University Partnership for Science and Security held at Stanford University on September 27-28, 2006. It was prepared by CASET Associates and is not an official report of The National Academies. Opinions and statements included in the transcript are solely those of the individual persons or participants at the workshop, and are not necessarily adopted or endorsed or verified as accurate by The National Academies. The National Academies Committee on a New Government-University Partnership for Science and Security September 28, 2006 Stanford University Bechtel Conference Center 616 Serra Mall, Encina Hall Stanford, CA Proceedings by: CASET Associates, Ltd. 10201 Lee Highway, suite 180 Fairfax, Virginia 22030 (703) 352-0091 NOTE: This is an unedited verbatim transcript of the Workshop on a New Government-University Partnership for Science and Security held at Stanford University on September 27-28, 2006. It was prepared by CASET Associates and is not an official report of The National Academies. Opinions and statements included in the transcript are solely those of the individual persons or participants at the workshop, and are not necessarily adopted or endorsed or verified as accurate by The National Academies. TABLE OF CONTENTS Page Introductions and Purpose of Meeting Jacques S. Gansler and Alice P. Gast 1 Security Concerns at National and University Laboratories Siegfried S. Hecker 3 Discussion 26 International Collaborations Jonathan Dorfan 40 Discussion 56 National Security and Academic Publishing Donald Kennedy 64 Discussion 77 Open Discussion: Moving Forward 86 NOTE: This is an unedited verbatim transcript of the Workshop on a New Government-University Partnership for Science and Security held at Stanford University on September 27-28, 2006.
    [Show full text]
  • The FDAAA's New Website
    Recipient of the Frances O. Kelsey Award for Courage and Excellence in Protecting the Public Health The FDAAA’s New Website (Still at www.fdaaa.org ) We are so pleased to unveil our new website. Not only is this modernized website more attractive and easier to follow, it has great new features such as members-only access to a growing collection of FDA- related information, a skills inventory, and the ability to chat with other members behind a secure firewall. This website will take us into a new era when FDAAA does even more to support your ongoing enrichment, connection to each other and to FDA, and your ability to locate resources, colleagues, friends, and experts. The FDA Alumni Association is the official global network of former and current FDA employees, connecting and supporting alumni, the Agency, and the public health community. Please be active in FDAAA and help us to make a difference. In speaking about FDAAA, then-Commissioner Ned Sharpless recently reminded us of a key quote from Margaret Mead: “Never doubt that a small group of thoughtful, committed citizens can change the world; indeed, it’s the only thing that ever has.” Members are encouraged to visit the Newsletter - Updates for the latest edition of the Newsletter, July 2020. Deb Autor, Chair Board of Directors FDA ALUMNI ASSOCIATION SAVE THE DATE…for our first FDA Alumni Association VIRTUAL Speaker Series Event! We are thrilled to have Dr. Luciana Borio (former Director for Medical and Biodefense Preparedness Policy for the White House National Security Council and former Acting Chief Scientist and Assistant Commissioner for Counterterrorism and Emerging Threats at FDA ) as our guest speaker on COVID-19 issues.
    [Show full text]
  • Improving the Efficiency of the Later Stages of the Drug Development Process: Survey Results from the Industry, Academia, and the FDA
    Improving the Efficiency of the Later Stages of the Drug Development Process: Survey Results from the Industry, Academia, and the FDA By Adrian Hedley Benjamin Gottschalk B.S. Biochemistry Texas A&M University, 1997 M.B.A. MIT Sloan School of Management, 2003 SUBMITTED TO THE HARVARD-MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF MASTER OF SCIENCE IN HEALTH SCIENCES AND TECHNOLOGY AT THE MASSACHUSETTS INSTITUTE OF TECHNOLOGY JUNE 2004 © 2004 Massachusetts Institute of Technology All rights reserved Signature of Author: ____________________________________________________________ Harvard-MIT Division of Health Sciences and Technology May 7, 2004 Certified by: __________________________________________________________________ Ernst R. Berndt Professor of Applied Economics Thesis Co-supervisor Certified by: __________________________________________________________________ Joseph V. Bonventre Professor of Medicine and Health Sciences and Technology Co-Director, Harvard-MIT Division of Health Sciences and Technology Thesis Co-supervisor Accepted by: __________________________________________________________________ Martha Gray Professor of Medical and Electrical Engineering Co-Director, Harvard-MIT Division of Health Sciences and Technology Improving the Efficiency of the Later Stages of the Drug Development Process: Survey Results from the Industry, Academia, and the FDA By Adrian Hedley Benjamin Gottschalk Submitted to the Harvard-MIT Division of Health Sciences and Technology on May 7, 2004 in Partial Fulfillment of the Requirements for the Degree of Master of Science in Biomedical Enterprise ABSTRACT Drug development in the United States is a lengthy and expensive endeavor. It is estimated that average development times range from eleven to fifteen years and exceed costs of one billion dollars. The development pathway includes basic scientific discovery, pre-clinical testing in animals, clinical development in humans, and an application process.
    [Show full text]